Provided by Tiger Trade Technology Pte. Ltd.

CareDx

49.60
+0.63001.29%
Post-market: 49.950.3500+0.71%16:01 EDT
Volume:825.14K
Turnover:40.92M
Market Cap:2.57B
PE:23.39
High:51.37
Open:49.55
Low:48.40
Close:48.97
52wk High:53.67
52wk Low:12.37
Shares:51.73M
Float Shares:48.55M
Volume Ratio:0.62
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.12
EPS(LYR):-0.4007
ROE:29.49%
ROA:-0.25%
PB:6.03
PE(LYR):-123.77

Loading ...

Press Release: Caredx to Report Second Quarter 2026 Financial Results on July 30, 2026

Dow Jones
·
Jul 16

Caredx Sets Webcast to Discuss Second-quarter 2026 Results After Market Close

Reuters
·
Jul 16

Caredx - Finalizes Medicare Local Coverage Determination for Solid Organ Transplant Molecular Testing

THOMSON REUTERS
·
Jul 16

Caredx - Final Lcd Published July 16, 2026; Effective August 30, 2026

THOMSON REUTERS
·
Jul 16

Caredx - Final Policy Affirms Coverage for Caredx Kidney, Heart, and Lung Transplant Surveillance

THOMSON REUTERS
·
Jul 16

CareDx Refocuses Portfolio With Naveris Oncology Acquisition

TIPRANKS
·
Jul 08

Caredx Completes Sale of Lab Products Unit to Eurobio Scientific for $171.2 Million Cash

Reuters
·
Jul 08

CareDx Closes Naveris Acquisition

MT Newswires Live
·
Jul 02

Caredx Completes Acquisition of Naveris, Extending Leadership into High-growth Specialty Oncology

THOMSON REUTERS
·
Jul 02

Caredx CEO John Walter Hanna Jr Disposes of USD 1.17 Million in Common Shares

Reuters
·
Jul 01

Caredx Completes Sale of Lab Products Unit to Eurobio Scientific for $171.2 Million Cash

Reuters
·
Jul 01

Caredx Announces Completion of Sale of Lab Products Business to Eurobio Scientific

THOMSON REUTERS
·
Jul 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: CareDx (CDNA) and Medtronic (MDT)

TIPRANKS
·
Jun 25

CareDx (CDNA) Stock Could Be 1.5% Overvalued After AlloSure Study Buzz

Simply Wall St.
·
Jun 22

How New AlloSure Kidney Prognostic Evidence At CareDx (CDNA) Has Changed Its Investment Story

Simply Wall St.
·
Jun 19

CareDx says study links early AlloSure elevation after kidney transplant to higher 3-year graft loss risk

Reuters
·
Jun 18

CareDx to present transplant diagnostics data at American Transplant Congress

Reuters
·
Jun 18

CareDx CEO John Walter Hanna Jr sells 17,683 shares worth $424,836

Reuters
·
Jun 18

Analysts’ Top Healthcare Picks: Certara (CERT), CareDx (CDNA)

TIPRANKS
·
Jun 17

CareDx director Hannah Valantine sells USD 279,705 of common shares

Reuters
·
Jun 17